SpinDiag
Spindiag is a medical technology company specializing in rapid, reliable PCR testing systems for infectious diseases, including antibiotic-resistant bacteria. They focus on point-of-care diagnostics that are fast, easy to use, and cost-effective, supporting infection control and antibiotic stewardship. Their products, such as Rhonda, enable testing within an hour directly at the patient site, facilitating quick clinical decisions and improved healthcare outcomes. The company actively participates in innovative projects and receives funding to advance personalized medicine, infection control, and healthcare research in Baden-Württemberg.
Industries
Nr. of Employees
medium (51-250)
SpinDiag
Patents
Products
Compact cartridge-based point-of-care multiplex PCR platform
Compact, automated cartridge/disk molecular testing platform designed for rapid, multiplex detection of infectious pathogens and antimicrobial-resistance markers at or near the patient; operates as a closed system compatible with standard swab samples.
Compact cartridge-based point-of-care multiplex PCR platform
Compact, automated cartridge/disk molecular testing platform designed for rapid, multiplex detection of infectious pathogens and antimicrobial-resistance markers at or near the patient; operates as a closed system compatible with standard swab samples.
Services
On-site deployment, commissioning and operational support for cartridge-based rapid molecular testing in clinical settings; includes demos and pilot arrangements and IT integration.
Collaborative involvement in regional surveillance and research initiatives to supply rapid screening technology and operational support for large-scale infection-control programs.
On-site deployment, commissioning and operational support for cartridge-based rapid molecular testing in clinical settings; includes demos and pilot arrangements and IT integration.
Collaborative involvement in regional surveillance and research initiatives to supply rapid screening technology and operational support for large-scale infection-control programs.
Expertise Areas
- Point-of-care molecular diagnostics
- Multiplex PCR assay development
- Infectious disease diagnostics and antimicrobial-resistance screening
- Clinical workflow integration and KIS/LIS interoperability
Key Technologies
- Multiplex PCR
- Sample-to-answer cartridge-based systems
- Closed-system automated sample handling
- Rapid thermal cycling / ultrafast PCR
News & Updates
SpinDiag completed a EUR 3 million financing round to finalize product development of their point-of-care system for antibiotic-resistant bacteria.
The Freiburg-based healthtech startup SpinDiag has closed a second financing round of EUR 3 million to complete the development of its rapid diagnostic system.
SpinDiag wins Innovation Award at Science4Life
SpinDiag was recognized for its innovative rapid PCR testing technology at the Science4Life Venture Cup.
SpinDiag secures 3 million euros in funding
The company successfully raised funds to advance its product development for antibiotic resistance testing.
SpinDiag completed a EUR 3 million financing round to finalize product development of their point-of-care system for antibiotic-resistant bacteria.
The Freiburg-based healthtech startup SpinDiag has closed a second financing round of EUR 3 million to complete the development of its rapid diagnostic system.
SpinDiag wins Innovation Award at Science4Life
SpinDiag was recognized for its innovative rapid PCR testing technology at the Science4Life Venture Cup.
SpinDiag secures 3 million euros in funding
The company successfully raised funds to advance its product development for antibiotic resistance testing.